Spastic paralysis in the following diseases: Cerebrovascular disease, spastic spinal paralysis, cervical spondylosis, post-op sequelae (including cerebrospinal tumor), sequelae to trauma (spinal trauma, head injury), amyotrophic lateral sclerosis, cerebral palsy, spinocerebellar degeneration, spinal vascular diseases & other encephalomyelopathies. Improvement of muscular hypertonic symptoms in the following: Cervical syndrome, periarthritis of the shoulder, lumbago.
Reduce the dose or discontinue treatment if the following are observed: Weakness, lightheadedness, sleepiness. Patients w/ hepatic function disorder. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn. Elderly.